Ironwood Pharmaceuticals, Inc. - stock earnings
IRWD Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 9, 2024 AfterMarket | - / 0.2052000000 | - | - / 108.4 million | - |
IRWD Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -1.1 million USD | 117.6 million USD |
| 2023Q3 | 15.3 million USD | 113.7 million USD |
| 2023Q2 | -1.1 billion USD | 107.4 million USD |
| 2023Q1 | 45.7 million USD | 104.1 million USD |
| 2022Q4 | 48.9 million USD | 107.2 million USD |
| 2022Q3 | 50.3 million USD | 108.6 million USD |
| 2022Q2 | 37.1 million USD | 97.2 million USD |
| 2022Q1 | 38.8 million USD | 97.5 million USD |
| 2021Q4 | 41.4 million USD | 117.1 million USD |
| 2021Q3 | 55.8 million USD | 103.7 million USD |
| 2021Q2 | 391.3 million USD | 104.0 million USD |
| 2021Q1 | 39.9 million USD | 88.8 million USD |
| 2020Q4 | 43.2 million USD | 116.7 million USD |
| 2020Q3 | 34.4 million USD | 103.5 million USD |
| 2020Q2 | 25.2 million USD | 89.4 million USD |
| 2020Q1 | 3.3 million USD | 79.9 million USD |
| 2019Q4 | 47.9 million USD | 126.3 million USD |
| 2019Q3 | 20.6 million USD | 131.2 million USD |
| 2019Q2 | 12.3 million USD | 102.2 million USD |
| 2019Q1 | -59.3 million USD | 68.7 million USD |
| 2018Q4 | -15.5 million USD | 130.7 million USD |
| 2018Q3 | -174.4 million USD | 65.7 million USD |
| 2018Q2 | -49.4 million USD | 81.1 million USD |
| 2018Q1 | -43.1 million USD | 69.2 million USD |
| 2017Q4 | 12.1 million USD | 94.2 million USD |
| 2017Q3 | -32.3 million USD | 86.8 million USD |
| 2017Q2 | -44.2 million USD | 65.1 million USD |
| 2017Q1 | -52.5 million USD | 52.2 million USD |
| 2016Q4 | -13.5 million USD | 87.5 million USD |
| 2016Q3 | -33.2 million USD | 66.1 million USD |
| 2016Q2 | -21.7 million USD | 54.4 million USD |
| 2016Q1 | -13.3 million USD | 66.0 million USD |
| 2015Q4 | -14.0 million USD | 53.3 million USD |
| 2015Q3 | -47.4 million USD | 39.6 million USD |
| 2015Q2 | -48.0 million USD | 27.7 million USD |
| 2015Q1 | -33.2 million USD | 28.9 million USD |
| 2014Q4 | -37.6 million USD | 38.1 million USD |
| 2014Q3 | -42.0 million USD | 16.9 million USD |
| 2014Q2 | -60.4 million USD | 6.8 million USD |
| 2014Q1 | -49.6 million USD | 14.6 million USD |
| 2013Q4 | -52.0 million USD | 5.0 million USD |
| 2013Q3 | -61.8 million USD | 4.9 million USD |
| 2013Q2 | -65.1 million USD | 9.7 million USD |
| 2013Q1 | -93.9 million USD | 3.3 million USD |
| 2012Q4 | -43.9 million USD | 27.0 million USD |
| 2012Q3 | 47.6 million USD | 96.4 million USD |
| 2012Q2 | -40.8 million USD | 14.6 million USD |
| 2012Q1 | -35.6 million USD | 12.2 million USD |
| 2011Q4 | -7.0 million USD | 32.2 million USD |
| 2011Q3 | -20.6 million USD | 12.2 million USD |
| 2011Q2 | -18.8 million USD | 11.3 million USD |
| 2011Q1 | -18.4 million USD | 10.2 million USD |
| 2010Q4 | -11.7 million USD | 16.8 million USD |
| 2010Q3 | -8.3 million USD | 9.1 million USD |
| 2010Q2 | -17.1 million USD | 11.0 million USD |
| 2010Q1 | -15.9 million USD | 9.1 million USD |
| 2009Q4 | -23.9 million USD | 8.6 million USD |
| 2009Q3 | -10.9 million USD | 15.3 million USD |
| 2009Q2 | -18.4 million USD | 6.6 million USD |
| 2009Q1 | -18.0 million USD | 5.2 million USD |
| 2008Q4 | -11.2 million USD | 5.0 million USD |
| 2007Q4 | ? USD | 10.5 million USD |
IRWD Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -1.0 billion USD | 442.7 million USD |
| 2022 | 175.1 million USD | 410.6 million USD |
| 2021 | 528.4 million USD | 413.8 million USD |
| 2020 | 106.2 million USD | 389.5 million USD |
| 2019 | -15.3 million USD | 428.4 million USD |
| 2018 | -282.4 million USD | 346.6 million USD |
| 2017 | -116.9 million USD | 298.3 million USD |
| 2016 | -81.7 million USD | 274.0 million USD |
| 2015 | -142.7 million USD | 149.6 million USD |
| 2014 | -189.6 million USD | 76.4 million USD |
| 2013 | -272.8 million USD | 22.9 million USD |
| 2012 | -72.6 million USD | 150.2 million USD |
| 2011 | -64.9 million USD | 65.9 million USD |
| 2010 | -53.0 million USD | 43.9 million USD |
| 2009 | -71.2 million USD | 36.1 million USD |
| 2008 | -53.9 million USD | 22.2 million USD |
| 2007 | -52.8 million USD | 10.5 million USD |
IRWD
Price: $8.12
52 week price:
Earnings Per Share: -6.45 USD
P/E Ratio: -2.43
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 405820
Ebitda: 26.2 millionMarket Capitalization: 1.2 billion